Literature DB >> 16728933

A checklist for evaluating reports of expression profiling for treatment selection.

Richard Simon1.   

Abstract

Oncologists need improved tools for selecting the right treatment for a given patient because many patients do not benefit from administered therapies. The use of expression profiling of tumors has increased dramatically and many claims are made for the value of expression signatures in treatment selection. It is difficult, however, for oncologists to critically evaluate published results in this technology- and statistics-intensive field. A checklist is presented to help oncologists evaluate publications on expression profiling of human tumors to determine whether the results are ready for use with their patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728933

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


  6 in total

1.  Tumor marker: a new standard of breast cancer care.

Authors:  Bob Carlson
Journal:  Biotechnol Healthc       Date:  2008-05

2.  Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

3.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.

Authors:  Michael J O'Connell; Ian Lavery; Greg Yothers; Soonmyung Paik; Kim M Clark-Langone; Margarita Lopatin; Drew Watson; Frederick L Baehner; Steven Shak; Joffre Baker; J Wayne Cowens; Norman Wolmark
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Translating RDoC to Real-World Impact in Developmental Psychopathology: A Neurodevelopmental Framework for Application of Mental Health Risk Calculators.

Authors:  Leigha A MacNeill; Norrina B Allen; Roshaye B Poleon; Teresa Vargas; K Juston Osborne; Katherine S F Damme; Deanna M Barch; Sheila Krogh-Jespersen; Ashley N Nielsen; Elizabeth S Norton; Christopher D Smyser; Cynthia E Rogers; Joan L Luby; Vijay A Mittal; Lauren S Wakschlag
Journal:  Dev Psychopathol       Date:  2021-12-07

5.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

6.  Planning clinically relevant biomarker validation studies using the "number needed to treat" concept.

Authors:  Roger S Day
Journal:  J Transl Med       Date:  2016-05-04       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.